<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>etoposide</title><link>http://www.unboundmedicine.com/medline/ebm/research/etoposide</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Case Report: First Reported Case of Disease: Peliosis Hepatis as Cardinal Symptom of Hodgkin's Lymphoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19889716/full_citation/Case_Report:_First_Reported_Case_of_Disease:_Peliosis_Hepatis_as_Cardinal_Symptom_of_Hodgkin's_Lymphoma_</link><description>Kleger A, Bommer M, Kunze M, et al. <br/><span class="title">Case Report: First Reported Case of Disease: Peliosis Hepatis as Cardinal Symptom of Hodgkin's Lymphoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="The oncologist">Oncologist 2009 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19889716/abstract/Case_Report:_First_Reported_Case_of_Disease:_Peliosis_Hepatis_as_Cardinal_Symptom_of_Hodgkin's_Lymphoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19889716/full_citation/Case_Report:_First_Reported_Case_of_Disease:_Peliosis_Hepatis_as_Cardinal_Symptom_of_Hodgkin's_Lymphoma_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19889716/Case_Report:_First_Reported_Case_of_Disease:_Peliosis_Hepatis_as_Cardinal_Symptom_of_Hodgkin's_Lymphoma_">Find Related Articles</a> </description></item><item><title>Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19889622/full_citation/Salvage_chemotherapy_with_alternating_MINE_ESHAP_regimen_in_relapsed_or_refractory_Hodgkin's_lymphoma_followed_by_autologous_stem_cell_transplantation_</link><description>Fernández de Larrea C, Martínez C, Gaya A, et al. <br/><span class="title">Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of oncology : official journal of the European Society for Medical Oncology / ESMO">Ann Oncol 2009 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19889622/abstract/Salvage_chemotherapy_with_alternating_MINE_ESHAP_regimen_in_relapsed_or_refractory_Hodgkin's_lymphoma_followed_by_autologous_stem_cell_transplantation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19889622/full_citation/Salvage_chemotherapy_with_alternating_MINE_ESHAP_regimen_in_relapsed_or_refractory_Hodgkin's_lymphoma_followed_by_autologous_stem_cell_transplantation_">Full Citation</a> | <a href="http://annonc.oxfordjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19889622">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19889622/Salvage_chemotherapy_with_alternating_MINE_ESHAP_regimen_in_relapsed_or_refractory_Hodgkin's_lymphoma_followed_by_autologous_stem_cell_transplantation_">Find Related Articles</a> </description></item><item><title>Multiple bulky cutaneous plasmacytomas with CNS relapse without bone marrow involvement during the course of a lambda light chain myeloma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19887870/full_citation/Multiple_bulky_cutaneous_plasmacytomas_with_CNS_relapse_without_bone_marrow_involvement_during_the_course_of_a_lambda_light_chain_myeloma_</link><description>Serefhanoglu S, Haznedaroglu IC, Goker H, et al. <br/><span class="title">Multiple bulky cutaneous plasmacytomas with CNS relapse without bone marrow involvement during the course of a lambda light chain myeloma. [Journal Article]</span><br/><span class="source" title="Onkologie">Onkologie 2009 Nov; 32(11):662-4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19887870/abstract/Multiple_bulky_cutaneous_plasmacytomas_with_CNS_relapse_without_bone_marrow_involvement_during_the_course_of_a_lambda_light_chain_myeloma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19887870/full_citation/Multiple_bulky_cutaneous_plasmacytomas_with_CNS_relapse_without_bone_marrow_involvement_during_the_course_of_a_lambda_light_chain_myeloma_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19887870/Multiple_bulky_cutaneous_plasmacytomas_with_CNS_relapse_without_bone_marrow_involvement_during_the_course_of_a_lambda_light_chain_myeloma_">Find Related Articles</a> </description></item><item><title>The Alkylphospholipid Perifosine Induces Apoptosis and p21-Mediated Cell Cycle Arrest in Medulloblastoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19887560/full_citation/The_Alkylphospholipid_Perifosine_Induces_Apoptosis_and_p21_Mediated_Cell_Cycle_Arrest_in_Medulloblastoma_</link><description>Kumar A, Fillmore HL, Kadian R, et al. <br/><span class="title">The Alkylphospholipid Perifosine Induces Apoptosis and p21-Mediated Cell Cycle Arrest in Medulloblastoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="Molecular cancer research : MCR">Mol Cancer Res 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19887560/abstract/The_Alkylphospholipid_Perifosine_Induces_Apoptosis_and_p21_Mediated_Cell_Cycle_Arrest_in_Medulloblastoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19887560/full_citation/The_Alkylphospholipid_Perifosine_Induces_Apoptosis_and_p21_Mediated_Cell_Cycle_Arrest_in_Medulloblastoma_">Full Citation</a></description></item><item><title>Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19887555/full_citation/Involvement_of_the_HER2_pathway_in_repair_of_DNA_damage_produced_by_chemotherapeutic_agents_</link><description>Boone JJ, Bhosle J, Tilby MJ, et al. <br/><span class="title">Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents. [JOURNAL ARTICLE]</span><br/><span class="source" title="Molecular cancer therapeutics">Mol Cancer Ther 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19887555/abstract/Involvement_of_the_HER2_pathway_in_repair_of_DNA_damage_produced_by_chemotherapeutic_agents_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19887555/full_citation/Involvement_of_the_HER2_pathway_in_repair_of_DNA_damage_produced_by_chemotherapeutic_agents_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19887555/Involvement_of_the_HER2_pathway_in_repair_of_DNA_damage_produced_by_chemotherapeutic_agents_">Find Related Articles</a> </description></item><item><title>Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19884539/full_citation/Phase_II_Trial_of_Concurrent_Radiation_and_Weekly_Cisplatin_Followed_by_VIPD_Chemotherapy_in_Newly_Diagnosed_Stage_IE_to_IIE_Nasal_Extranodal_NK/T_Cell_Lymphoma:_Consortium_for_Improving_Survival_of_Lymphoma_Study_</link><description>Kim SJ, Kim K, Kim BS, et al. <br/><span class="title">Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of clinical oncology : official journal of the American Society of Clinical Oncology">J Clin Oncol 2009 Nov 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19884539/abstract/Phase_II_Trial_of_Concurrent_Radiation_and_Weekly_Cisplatin_Followed_by_VIPD_Chemotherapy_in_Newly_Diagnosed_Stage_IE_to_IIE_Nasal_Extranodal_NK/T_Cell_Lymphoma:_Consortium_for_Improving_Survival_of_Lymphoma_Study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19884539/full_citation/Phase_II_Trial_of_Concurrent_Radiation_and_Weekly_Cisplatin_Followed_by_VIPD_Chemotherapy_in_Newly_Diagnosed_Stage_IE_to_IIE_Nasal_Extranodal_NK/T_Cell_Lymphoma:_Consortium_for_Improving_Survival_of_Lymphoma_Study_">Full Citation</a> | <a href="http://www.jco.org/cgi/pmidlookup%3fview=long%26amp;pmid=19884539">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19884539/Phase_II_Trial_of_Concurrent_Radiation_and_Weekly_Cisplatin_Followed_by_VIPD_Chemotherapy_in_Newly_Diagnosed_Stage_IE_to_IIE_Nasal_Extranodal_NK/T_Cell_Lymphoma:_Consortium_for_Improving_Survival_of_Lymphoma_Study_">Find Related Articles</a> </description></item><item><title>Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?</title><link>http://www.unboundmedicine.com/medline/ebm/record/19883301/full_citation/Is_there_a_role_for_BEACOPP__bleomycin_etoposide_adriamycin_cyclophosphamide_vincristine_procarbazine_prednisone__in_relapsed_Hodgkin_lymphoma</link><description>Eichenauer DA, Engert A <br/><span class="title">Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma? [JOURNAL ARTICLE]</span><br/><span class="source" title="Leukemia &amp; lymphoma">Leuk Lymphoma 2009 Nov; 50(11):1733-1734.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19883301/full_citation/Is_there_a_role_for_BEACOPP__bleomycin_etoposide_adriamycin_cyclophosphamide_vincristine_procarbazine_prednisone__in_relapsed_Hodgkin_lymphoma">Full Citation</a></description></item><item><title>Heterogeneity of adenosine triphosphate-based chemotherapy response assay in colorectal cancer--secondary publication.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19881975/full_citation/Heterogeneity_of_adenosine_triphosphate_based_chemotherapy_response_assay_in_colorectal_cancer__secondary_publication_</link><description>Huh JW, Park YA, Lee KY, et al. <br/><span class="title">Heterogeneity of adenosine triphosphate-based chemotherapy response assay in colorectal cancer--secondary publication. [Journal Article]</span><br/><span class="source" title="Yonsei medical journal">Yonsei Med J 2009 Oct 31; 50(5):697-703.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19881975/abstract/Heterogeneity_of_adenosine_triphosphate_based_chemotherapy_response_assay_in_colorectal_cancer__secondary_publication_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19881975/full_citation/Heterogeneity_of_adenosine_triphosphate_based_chemotherapy_response_assay_in_colorectal_cancer__secondary_publication_">Full Citation</a></description></item><item><title>A novel Podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-gp in multidrug resistance cell line KBV200.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19879873/full_citation/A_novel_Podophyllotoxin_derivative__YB_1EPN__induces_apoptosis_and_down_regulates_express_of_P_gp_in_multidrug_resistance_cell_line_KBV200_</link><description>Chen H, Bi W, Cao B, et al. <br/><span class="title">A novel Podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-gp in multidrug resistance cell line KBV200. [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of pharmacology">Eur J Pharmacol 2009 Oct 29.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19879873/abstract/A_novel_Podophyllotoxin_derivative__YB_1EPN__induces_apoptosis_and_down_regulates_express_of_P_gp_in_multidrug_resistance_cell_line_KBV200_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19879873/full_citation/A_novel_Podophyllotoxin_derivative__YB_1EPN__induces_apoptosis_and_down_regulates_express_of_P_gp_in_multidrug_resistance_cell_line_KBV200_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19879873/A_novel_Podophyllotoxin_derivative__YB_1EPN__induces_apoptosis_and_down_regulates_express_of_P_gp_in_multidrug_resistance_cell_line_KBV200_">Find Related Articles</a> </description></item><item><title>Clusterin and chemoresistance.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19879424/full_citation/Clusterin_and_chemoresistance_</link><description>Djeu JY, Wei S <br/><span class="title">Clusterin and chemoresistance. [Journal Article]</span><br/><span class="source" title="Advances in cancer research">Adv Cancer Res 2009.:77-92.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19879424/abstract/Clusterin_and_chemoresistance_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19879424/full_citation/Clusterin_and_chemoresistance_">Full Citation</a></description></item></channel></rss>